Two analysts have upgraded NUS to "buy"
Nu Skin Enterprises, Inc. (NYSE:NUS) is soaring today, up 18.8% at $45.68 at last check, after the company raised its second-quarter revenue forecast, now anticipating $603 million to $608 million. Following the adjustment, two analysts
upgraded the stock to "buy" -- D.A. Davidson from "neutral," with a price-target hike to $54 from $35, and Jefferies from "hold," raising its price target to $50 from $42.
Prior to today's pop, NUS was seeing pressure from the 320-day moving average at the $40 region, though it had still tripled its mid-March lows of $12.30. Currently, the stock is up 15% year-to-date following an impressive 136.7% three-month gain.
Coming into today, five out of six analysts sport a tepid "hold" rating on Nu Skin stock, with the remainder at a "sell." Meanwhile, the 12-month consensus price target of $42.29 is now a 9.6% discount to current levels, leaving plenty of room for more
upgrades and price-target hikes in the near future.
Also worth noting is NUS' Schaeffer's Volatility Index (SVI) of 40%, which stands higher than just 8% of all other readings in its annual range. This implies that options players are pricing in relatively low volatility expectations at the moment.